Using propensity scores to estimate effects of treatment initiation decisions: state of the science
Using them together could potentially lead to an increase in the likelihood or intensity of certain reactions
While Semaglutide is primarily known for its metabolic benefits, some women report improved mood and energy levels while on the medication
It requires no injection, has excellent safety data, and is widely available
Adult Obesity Facts, CDC Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial, Obesity (2020) Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity, The New England Journal of Medicine (2023) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects, Frontiers in Endocrinology (2021) Wegovy: Understanding list price, NovoCare How much should I expect to pay for Mounjaro?, Lilly (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Adverse events leading to treatment discontinuation occurred in 21% of the semaglutide group and 13.9% of the placebo group
